These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. EPHB4 tyrosine-kinase receptor expression and biological significance in soft tissue sarcoma. Becerikli M; Merwart B; Lam MC; Suppelna P; Rittig A; Mirmohammedsadegh A; Stricker I; Theiss C; Singer BB; Jacobsen F; Steinstraesser L Int J Cancer; 2015 Apr; 136(8):1781-91. PubMed ID: 25274141 [TBL] [Abstract][Full Text] [Related]
45. Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts. Huang R; Andersen LMK; Rofstad EK J Transl Med; 2017 Oct; 15(1):203. PubMed ID: 29017512 [TBL] [Abstract][Full Text] [Related]
46. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue. Ozgür E; Heidenreich A; Dagtekin O; Engelmann U; Bloch W Urol Oncol; 2011; 29(1):78-84. PubMed ID: 19272799 [TBL] [Abstract][Full Text] [Related]
47. EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer. Lv J; Xia Q; Wang J; Shen Q; Zhang J; Zhou X Exp Mol Pathol; 2016 Jun; 100(3):402-8. PubMed ID: 27072105 [TBL] [Abstract][Full Text] [Related]
48. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy. Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639 [TBL] [Abstract][Full Text] [Related]
49. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Noren NK; Foos G; Hauser CA; Pasquale EB Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147 [TBL] [Abstract][Full Text] [Related]
51. Communication between ephrinB2 and EphB4 within the osteoblast lineage. Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015 [TBL] [Abstract][Full Text] [Related]
52. Hypoxia: dual effect on the expression of transferrin receptor in human melanoma A375 cell line. Tao J; Liu YQ; Li Y; Peng JL; Li L; Liu J; Shen X; Shen GX; Tu YT Exp Dermatol; 2007 Nov; 16(11):899-904. PubMed ID: 17927572 [TBL] [Abstract][Full Text] [Related]
53. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063 [TBL] [Abstract][Full Text] [Related]
54. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study. Yu SJ; Long ZW Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787 [TBL] [Abstract][Full Text] [Related]
55. Comparative preclinical evaluation of Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651 [TBL] [Abstract][Full Text] [Related]
56. Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET. Geven EJ; Evers S; Nayak TK; Bergström M; Su F; Gerrits D; Franssen GM; Boerman OC Contrast Media Mol Imaging; 2015; 10(3):203-10. PubMed ID: 25204436 [TBL] [Abstract][Full Text] [Related]
57. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1. Zhang JS; Wang YZ; Hu YQ; Lin F; Gao D; Song J; Kaptchuk TJ; Chen KJ Chin J Integr Med; 2016 Aug; 22(8):605-10. PubMed ID: 27299459 [TBL] [Abstract][Full Text] [Related]
58. Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IR Scalia P; Pandini G; Carnevale V; Giordano A; Williams SJ Oncogene; 2019 Aug; 38(31):5987-6001. PubMed ID: 31270394 [TBL] [Abstract][Full Text] [Related]
59. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789 [TBL] [Abstract][Full Text] [Related]